U.S. judge tosses verdict against AbbVie in AndroGel case
(Reuters) - A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc that was first to result from lawsuits claiming that the company fraudulently misrepresented the risks of its testosterone replacement drug AndroGel.
from Reuters: Health News http://reut.rs/2l0JNen
http://bit.ly/2zwRqiM